● Latest
Generalised Anxiety Disorder and Panic Disorder in Adults (NICE CG113) Early Breast Cancer: Diagnosis and Management (NICE NG101) Depression in Adults: Treatment and Management (NICE NG222) Dementia: Assessment, Management and Support (NICE NG97) Epilepsies: Diagnosis and Management (NICE NG217, 2022 update) Lung Cancer: Diagnosis and Management (NICE NG122)
') repeat">
GLOBAL MARKET RESEARCH

UK-Led Market Research
for Global Pharma Teams

ClinicaliQ provides high-quality UK HCP research as part of global and European multi-country studies — with partner network coverage across DE, FR, ES, IT and beyond. One commercial relationship. One quality standard. EFPIA and ABPI compliant.

Request a Proposal → View Capabilities
10,000+
Verified UK HCPs
5
EU Country Partners
2–5 days
Quant Turnaround
94%
GMC-Verified Panel
EFPIA
Code Compliant
GDPR
EU Data Compliant
Why include UK

The UK is Essential to Any Global Study

Post-Brexit, the UK is now a distinct regulatory and market access jurisdiction. Global teams that exclude UK data are missing a critical data point.

🎕

Separate MHRA Jurisdiction

Post-Brexit, MHRA operates independently of EMA. UK approval timelines and label differences directly affect global market access strategy.

📊

NICE HTA Decisions

NICE appraisals are globally benchmarked. Payers worldwide reference NICE cost-effectiveness decisions. UK HCP insight on NICE outcomes is uniquely valuable.

🌐

Large, Accessible HCP Pool

10,000+ verified UK HCPs across all specialties — rapid fieldwork completion with high-quality, low-dropout respondents.

📋

NHS Prescribing Data

NHS OpenPrescribing data gives UK HCP responses unique context for formulary and prescribing behaviour research.

Fastest EU-Adjacent Turnaround

UK fieldwork typically completes in 2–4 working days — often faster than any EU5 market — allowing rapid insight for global timelines.

🔑

Robust Data Quality

GMC-verified panel with professional email validation. No panel pollution, no fraudulent responses common in open-access panels.

Capabilities

Full-Service Research for Global Teams

From rapid quantitative surveys to multi-country advisory boards — scoped and executed to global pharma standards.

📈

Multi-Country Quantitative

UK + EU5 quant surveys with harmonised questionnaires, parallel fieldwork, and unified analysis. Typical n=50–200 per country.

UK DE FR ES IT NL
💬

Global HCP Depth Interviews

IDIs with key opinion leaders, prescribers and specialists across UK and European markets. Multilingual moderation available.

KOL interviews Translated transcripts Thematic analysis
🌟

International Advisory Boards

Virtual advisory panels with 6–12 HCPs across UK + EU. Full facilitation, verbatim reporting, and EFPIA-compliant honoraria management.

UK + EU panels EFPIA honoraria Full facilitation
🎯

Global Concept & Message Testing

Test brand positioning, IVAs, patient materials and messaging with HCPs across multiple markets before global launch.

Pre-launch testing Material review Positioning studies
🔎

Landscape & Unmet Needs

Treatment algorithm mapping, competitive intelligence, and unmet need assessments across UK and European markets.

Pathway mapping Competitive intel Gap analysis
📋

HEOR & Market Access

HCP perspectives on cost-effectiveness, payer value messaging, and access barriers — aligned to NICE, HAS, IQWIG and other HTA bodies.

HTA perspectives Value dossier input Access barriers
Partner Network

UK + EU Coverage

ClinicaliQ leads UK fieldwork and coordinates with established HCP research partners across Europe — one brief, one commercial relationship, one report.

🇬🇧
United Kingdom
ClinicaliQ (direct)
LEAD MARKET
🇩🇪
Germany
Partner agency
🇫🇷
France
Partner agency
🇪🇸
Spain
Partner agency
🇮🇹
Italy
Partner agency
🇳🇱
Netherlands
Partner agency
🇺🇸
USA
On request
🌍
Other markets
On request
Compliance Standards
ABPI Code 2024 UK — Clauses 10 & 23
EFPIA Code EU-wide standard
BHBIA Guidelines UK market research
IFPMA Code Global standard
PhRMA Code US (on request)
Our Commitments
All research is non-promotional — no disguised promotion
Written agreements with all HCP participants
Fair market value honoraria under EFPIA/BHBIA guidance
Commissioning company disclosed to participants on request
Full GDPR compliance with EU data residency options
ICH E6(R3) GCP standards for observational studies
Need a compliance briefing?

We can provide a full compliance summary for your procurement or legal team before project commencement.

Request Compliance Pack
Get Started

Request a Global Research Proposal

Tell us your research objectives and target markets. We'll respond with a scoped proposal and indicative pricing within 24 hours.

24-hour response
Scoped proposal with indicative pricing and timeline
🌐
Multi-country coordination
Single point of contact for UK + EU fieldwork
📋
EFPIA & ABPI compliant
Compliance pack available for procurement teams

We respond within 24 hours. All enquiries are confidential.

Join 10,000+ UK Clinicians

Get weekly clinical updates — guidelines, trials, MHRA alerts — delivered to your inbox. Free for verified HCPs.

By registering you confirm you are a healthcare professional. No spam. Unsubscribe anytime.